Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study
暂无分享,去创建一个
Hyuk Hur | J. Roh | N. Kim | H. Hur | K. Lee | Dae Ryong Kang | S. Shin | T. Kim | J. Ahn | Kang Young Lee | Nam Kyu Kim | H. Chung | Se Hyun Kim | Se Hyun Kim | Sang Joon Shin | Hyunki Kim | Tae Il Kim | Dae Ryong Kang | Byung So Min | Hyun Chul Chung | Jae Kyung Roh | Joong Bae Ahn | B. Min | Hyun-Keun Kim
[1] J. Cubiella,et al. 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer. , 2011, Gastroenterology.
[2] M E Hammond,et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. , 2000, Archives of pathology & laboratory medicine.
[3] E. Seim,et al. Influence of mucinous components on survival in colorectal adenocarcinomas: a multivariate analysis. , 1988, Journal of clinical pathology.
[4] C. Ko,et al. A 10-Year Outcomes Evaluation of Mucinous and Signet-Ring Cell Carcinoma of the Colon and Rectum , 2005, Diseases of the colon and rectum.
[5] J. Herman,et al. Low-level microsatellite instability in most colorectal carcinomas. , 2002, Cancer research.
[6] Chen Han-Shiang. Curative Resection of Colorectal Adenocarcinoma: Multivariate Analysis of 5-Year Follow-up , 1999, World Journal of Surgery.
[7] Y. Kodera,et al. Survival After Curative Resection for Mucinous Adenocarcinoma of the Colorectum , 2003, Diseases of the colon and rectum.
[8] R. Costi,et al. Two Subtypes of Mucinous Adenocarcinoma of the Colorectum: Clinicopathological and Genetic Features , 2008, Annals of Surgical Oncology.
[9] S. Kakar,et al. Mucinous carcinomas of the colorectum have distinct molecular genetic characteristics. , 2005, International journal of oncology.
[10] D. Parkin,et al. Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.
[11] Shung-Haur Yang,et al. Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute , 2009, International Journal of Colorectal Disease.
[12] J. Jass. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.
[13] Daniel J Sargent,et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] S Srivastava,et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.
[15] V. Catalano,et al. Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy , 2009, British Journal of Cancer.
[16] R. Houlston,et al. Systematic review of microsatellite instability and colorectal cancer prognosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Clive R. Taylor,et al. Prognostic factors in colorectal cancer , 2009 .
[18] M. Chew,et al. Improved survival in an Asian cohort of young colorectal cancer patients: an analysis of 523 patients from a single institution , 2009, International Journal of Colorectal Disease.
[19] M. Pollheimer,et al. Mucinous differentiation in colorectal cancer – indicator of poor prognosis? , 2012, Histopathology.
[20] Stanley R. Hamilton,et al. Pathology and genetics of tumours of the digestive system , 2000 .
[21] V. Catalano,et al. Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] C. Ratto,et al. Prognostic factors in colorectal cancer , 1998, Diseases of the colon and rectum.
[23] A. Jemal,et al. Global Cancer Statistics , 2011 .
[24] P. Catalano,et al. Association between DNA Methylation and Shortened Survival in Patients with Advanced Colorectal Cancer Treated with 5-Fluorouracil–Based Chemotherapy , 2007, Clinical Cancer Research.
[25] J. Guillem,et al. Signet-ring cell carcinoma of the colon and rectum , 1999 .
[26] Yan Xing,et al. Clinicopathology and Outcomes for Mucinous and Signet Ring Colorectal Adenocarcinoma: Analysis from the National Cancer Data Base , 2012, Annals of Surgical Oncology.
[27] C. Compton,et al. Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] S. Kawauchi,et al. Two subtypes of mucinous colorectal carcinoma characterized by laser scanning cytometry and comparative genomic hybridization. , 2004, International journal of oncology.
[29] A. Norman,et al. Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[30] F. Consorti,et al. Prognostic significance of mucinous carcinoma of colon and rectum: A prospective case‐control study , 2000, Journal of surgical oncology.
[31] P. Demetter,et al. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis , 2012, Journal of Clinical Pathology.
[32] 田中 宏史. BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer , 2007 .
[33] M. Loda,et al. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component , 2006, Modern Pathology.